218 WuolikainenA.JonssonP.AhnlundM.AnttiH.MarklundS
The incidence of 12 types of respiratory diseases was evaluated, although their incidence was overall very low, the lowest for interstitial lung disease (0.02% in the GLP-1 receptor agonist group and 0.04% in the control group) and the highest for pneumonia (2.05% in the GLP-1 receptor agonist group and 2.31% in the placebo group)
Containers (00:40:50) Discomfort: Marker of Movement, Failures & Learning (00:47:05) Movement Diversity, Squat Challenge, Injury, Movement Evolution (00:56:36) Animal & Human Movements, Gain & Change (01:02:04) Core Movement, Emotion & Memory, Spinal Waves, Evolution (01:12:39) Song, Dance & Complex Language, Movement as Language, Consilience (01:21:39) Movement Culture, Community, Collective Knowledge, Wild & Wise (01:26:36) Potential for Movement, Humming (01:32:18) Instructiveness vs Permissiveness, Degrees of Freedom (01:35:50) Variety, Diversity & Virtuosity (01:38:06) Vision & Movement, Focus & Awareness, Panoramic Awareness (01:48:28) Hearing & Movement (01:52:43) Walking Gaits (01:56:55) Playful Variability & Evolution, Improvisation & Openness (02:03:05) Reactivity & Personal Space, Touch & Proximity to Others, Play & Discomfort (02:18:13) Visualization & Experience, Feedback (02:20:14) Linear Movement & Movement Investigation, Examination (02:31:45) Zero-Cost Support, YouTube Feedback, Spotify & Apple Reviews, Sponsors, Momentous Supplements, Instagram, Twitter, Neural Network Newsletter Title Card Photo Credit: Mike Blabac Disclaimer Day 77 The Science & Treatment of Obsessive-Compulsive Disorder (OCD) | Episode 78 In this episode, I explain the biology and psychology of obsessive-compulsive disorder (OCD)a prevalent and debilitating condition
GH secretagogues stimulate upstream signaling that can increase endogenous GH release, while HGH directly supplies the hormone
Role of lysosome rupture in controlling Nlrp3 signaling and necrotic cell death
And now its having a huge clinical impact globally, which is just great to see as a physician. Drucker, along with others in the scientific community, wanted to turn GLP-1 into a drug to help people manage Type 2 diabetes
